Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-064659)

Filing Details

Accession Number:: 0001209191-20-064659
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-21 16:47:04
Reporting Period:: 2020-12-17

Accepted Time:: 2020-12-21 16:47:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1672619	Imara Inc.	IMRA	Pharmaceutical Preparations (2834)	811523849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1805097	D. Rahul Ballal	C/O Imara Inc. 116 Huntington Avenue, 6Th Floor Boston MA 02116	Chief Executive Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-17	4,999	$3.15	4,999	No	4	M	Direct
Common Stock	Disposition	2020-12-17	4,999	$25.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-12-17	4,999	$0.00	4,999	$3.15

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
263,999		2028-10-18	No	4	M	Direct

Footnotes

Transaction made pursuant to Dr. Ballal's trading plan under Rule 10b5-1.
The option was granted on October 19, 2018. The shares underlying the option vest over four years, with 25% of the shares vested on May 29, 2019 and the remaining shares vesting in equal quarterly installments thereafter.